7351 - 7375 of 8673 Results
Title
Year
-
OPENTitle: Spatially informed Bayesian neural network for neurodegenerative diseases classificationJournal Name: Statistics in MedicinePublisher: WileyVol: 42Issue #: 2Start Page: 105End Page: 121Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/sim.9604Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/sim.9604Citation Count: 12
- Objective screening for olfactory and gustatory dysfunction during the COVID‐19 pandemic: A prospective study in healthcare workers using self‐administered testing2021OPENTitle: Objective screening for olfactory and gustatory dysfunction during the COVID‐19 pandemic: A prospective study in healthcare workers using self‐administered testingJournal Name: World Journal of Otorhinolaryngology - Head and Neck SurgeryPublisher: WileyVol: 8Issue #: 3Start Page: 249End Page: 256Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1016/j.wjorl.2021.02.001Best OA location URL: https://doi.org/10.1016/j.wjorl.2021.02.001Citation Count: 32
- Electrocorticography is superior to subthalamic local field potentials for movement decoding in Parkinson’s disease2022OPENTitle: Electrocorticography is superior to subthalamic local field potentials for movement decoding in Parkinson’s diseaseJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 11Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.7554/elife.75126Best OA location URL: https://doi.org/10.7554/elife.75126Citation Count: 60
-
OPENTitle: Mapping dopaminergic projections in the human brain with resting-state fMRIJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 11Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.7554/elife.71846Best OA location URL: https://doi.org/10.7554/elife.71846Citation Count: 36
-
OPENTitle: SymposiaJournal Name: European Journal of NeurologyPublisher: WileyVol: 29Issue #: S1Start Page: 6End Page: 19Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/ene.15461Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/ene.15461Citation Count: 2
- Comparative pharmacovigilance assessment of mortality with pimavanserin in Parkinson disease-related psychosis2021OPENTitle: Comparative pharmacovigilance assessment of mortality with pimavanserin in Parkinson disease-related psychosisJournal Name: Journal of Managed Care & Specialty PharmacyPublisher: Academy of Managed Care PharmacyVol: 27Issue #: 6Start Page: 785End Page: 790Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.18553/jmcp.2021.27.6.785Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10391001/pdf/jmcp.2021.27.6.785.pdfCitation Count: 10
- Longitudinal clustering analysis and prediction of Parkinson’s disease progression using radiomics and hybrid machine learning2021OPENTitle: Longitudinal clustering analysis and prediction of Parkinson’s disease progression using radiomics and hybrid machine learningJournal Name: Quantitative Imaging in Medicine and SurgeryPublisher: AME Publishing CompanyVol: 12Issue #: 2Start Page: 906End Page: 919Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.21037/qims-21-425Best OA location URL: https://qims.amegroups.com/article/viewFile/78913/pdfCitation Count: 29
-
OPENTitle: An efficient and scalable synthesis of thiazolo ring fused 2-pyridones using flow chemistryJournal Name: ArkivocPublisher: ARKAT USA, Inc.Vol: 2020Issue #: 7Start Page: 365End Page: 378Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.24820/ark.5550190.p011.445Best OA location URL: https://www.arkat-usa.org/get-file/72918/Citation Count: 0
- Reprogramming of Nucleotide Metabolism Mediates Synergy between Epigenetic Therapy and MAP Kinase Inhibition2020OPENTitle: Reprogramming of Nucleotide Metabolism Mediates Synergy between Epigenetic Therapy and MAP Kinase InhibitionJournal Name: Molecular Cancer TherapeuticsPublisher: American Association for Cancer Research (AACR)Vol: 20Issue #: 1Start Page: 64End Page: 75Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1158/1535-7163.mct-20-0259Best OA location URL: https://aacrjournals.org/mct/article-pdf/20/1/64/1866868/64.pdfCitation Count: 13
-
RESTRICTEDTitle: Population-specific neuromodulation prolongs therapeutic benefits of deep brain stimulationJournal Name: SciencePublisher: American Association for the Advancement of Science (AAAS)Vol: 374Issue #: 6564Start Page: 201End Page: 206Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1126/science.abi7852Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/11098594Citation Count: 127
- Dysregulation of the AP2M1 phosphorylation cycle by LRRK2 impairs endocytosis and leads to dopaminergic neurodegeneration2021OPENTitle: Dysregulation of the AP2M1 phosphorylation cycle by LRRK2 impairs endocytosis and leads to dopaminergic neurodegenerationJournal Name: Science SignalingPublisher: American Association for the Advancement of Science (AAAS)Vol: 14Issue #: 693Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/scisignal.abg3555Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8486338Citation Count: 26
-
OPENTitle: PARIS farnesylation prevents neurodegeneration in models of Parkinson’s diseaseJournal Name: Science Translational MedicinePublisher: American Association for the Advancement of Science (AAAS)Vol: 13Issue #: 604Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/scitranslmed.aax8891Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9990146Citation Count: 54
- Radiosynthesis, In Vitro and In Vivo Evaluation of [18F]CBD-2115 as a First-in-Class Radiotracer for Imaging 4R-Tauopathies2021OPENTitle: Radiosynthesis, In Vitro and In Vivo Evaluation of [18F]CBD-2115 as a First-in-Class Radiotracer for Imaging 4R-TauopathiesJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 12Issue #: 4Start Page: 596End Page: 602Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acschemneuro.0c00801Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/9350900Citation Count: 46
- [125I]IPPI for Tau Imaging: Binding Studies in Postmortem Human Alzheimer's Disease Hippocampus‐Subiculum and Evaluation of Drug Effects2025OPENTitle: [125I]IPPI for Tau Imaging: Binding Studies in Postmortem Human Alzheimer's Disease Hippocampus‐Subiculum and Evaluation of Drug EffectsJournal Name: SynapsePublisher: WileyVol: 79Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/syn.70024Best OA location URL: https://escholarship.org/uc/item/42g3p7cqCitation Count: 0
- Reduction in [18F]Nifene Binding, a PET imaging Probe for α4β2* Nicotinic acetylcholinergic receptors in Hippocampus-Subiculum of postmortem human Alzheimer’s disease brain2025OPENTitle: Reduction in [18F]Nifene Binding, a PET imaging Probe for α4β2* Nicotinic acetylcholinergic receptors in Hippocampus-Subiculum of postmortem human Alzheimer’s disease brainJournal Name: Brain ResearchPublisher: Elsevier BVVol: 1857Issue #:Start Page: 149600End Page: 149600Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.brainres.2025.149600Best OA location URL: https://doi.org/10.1016/j.brainres.2025.149600Citation Count: 1
- ELFN1 deficiency: The mechanistic basis and phenotypic spectrum of a neurodevelopmental disorder with epilepsy2025OPENTitle: ELFN1 deficiency: The mechanistic basis and phenotypic spectrum of a neurodevelopmental disorder with epilepsyJournal Name: Genetics in MedicinePublisher: Elsevier BVVol: 27Issue #: 9Start Page: 101506End Page: 101506Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.gim.2025.101506Best OA location URL: https://doi.org/10.1016/j.gim.2025.101506Citation Count: 0
- Interpretable deep learning framework for understanding molecular changes in human brains with Alzheimer’s disease: implications for microglia activation and sex differences2025OPENTitle: Interpretable deep learning framework for understanding molecular changes in human brains with Alzheimer’s disease: implications for microglia activation and sex differencesJournal Name: npj AgingPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1038/s41514-025-00258-5Best OA location URL: https://www.nature.com/articles/s41514-025-00258-5.pdfCitation Count: 0
- GDNF overexpression in astrocytes enhances branching and partially preserves hippocampal function in an Alzheimer’s rat model2025OPENTitle: GDNF overexpression in astrocytes enhances branching and partially preserves hippocampal function in an Alzheimer’s rat modelJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-025-02881-4Best OA location URL: https://www.nature.com/articles/s41598-025-02881-4.pdfCitation Count: 0
- Estimating motor symptom presence and severity in Parkinson’s disease from wrist accelerometer time series using ROCKET and InceptionTime2025OPENTitle: Estimating motor symptom presence and severity in Parkinson’s disease from wrist accelerometer time series using ROCKET and InceptionTimeJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-025-04263-2Best OA location URL: https://www.nature.com/articles/s41598-025-04263-2.pdfCitation Count: 0
- Preprint Highlight: ER-lysosome lipid transfer protein VPS13C/PARK23 prevents aberrant mtDNA- dependent STING signaling2022RESTRICTEDTitle: Preprint Highlight: ER-lysosome lipid transfer protein VPS13C/PARK23 prevents aberrant mtDNA- dependent STING signalingJournal Name: Molecular Biology of the CellPublisher: American Society for Cell Biology (ASCB)Vol: 33Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1091/mbc.p22-02-1003Citation Count: 0
-
RESTRICTEDTitle: Expanding the phenotype of PPP1R21‐related neurodevelopmental disorderJournal Name: Clinical GeneticsPublisher: WileyVol: 105Issue #: 6Start Page: 620End Page: 629Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/cge.14492Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/11065596Citation Count: 4
-
OPENTitle: Type II kinase inhibitors that target Parkinson’s disease–associated LRRK2Journal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 11Issue #: 23Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1126/sciadv.adt2050Best OA location URL: https://doi.org/10.1126/sciadv.adt2050Citation Count: 0
- Associations between neuropsychiatric symptoms and pathology in clinicopathologically defined Alzheimer's disease, Alzheimer's disease with Lewy bodies, and dementia with Lewy bodies2025RESTRICTEDTitle: Associations between neuropsychiatric symptoms and pathology in clinicopathologically defined Alzheimer's disease, Alzheimer's disease with Lewy bodies, and dementia with Lewy bodiesJournal Name: Journal of Alzheimer’s DiseasePublisher: SAGE PublicationsVol: 104Issue #: 3Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1177/13872877251320670Citation Count: 0
- Integrated Proteomics Reveals Brain-Based Cerebrospinal Fluid Biomarkers in Asymptomatic and Symptomatic Alzheimer’s Disease (4738)2020OPENTitle: Integrated Proteomics Reveals Brain-Based Cerebrospinal Fluid Biomarkers in Asymptomatic and Symptomatic Alzheimer’s Disease (4738)Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 94Issue #: 15_supplementStart Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.94.15_supplement.4738Citation Count: 6
- Loss of Lysosomal Proteins Progranulin and Prosaposin Associated with Increased Neurofibrillary Tangle Development in Alzheimer Disease2021OPENTitle: Loss of Lysosomal Proteins Progranulin and Prosaposin Associated with Increased Neurofibrillary Tangle Development in Alzheimer DiseaseJournal Name: Journal of Neuropathology & Experimental NeurologyPublisher: Oxford University Press (OUP)Vol: 80Issue #: 8Start Page: 741End Page: 753Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/jnen/nlab056Best OA location URL: https://academic.oup.com/jnen/article-pdf/80/8/741/40347160/nlab056.pdfCitation Count: 12